Sisi Chan

Investors quietly pile into a group of stocks for 2026 (it’s not tech)

In a surprising development, healthcare stocks have begun to outperform technology, long considered the dominant player in the S&P 500. This trend is driven by several key factors:

• Rising healthcare earnings outpacing those in tech
• The diminishing influence of tech stocks in the S&P 500
• Increased investor momentum toward healthcare

With extensive experience in sector trend analysis, the authors provide in-depth insights into this shift.

Over the summer of 2025, healthcare stocks led an impressive rally, leaving tech in their wake. Limelight Alpha’s Sector Ranking confirms this upward trend. The diversification into healthcare isn’t a faulty strategy; instead, it turns down tech’s dominance in the S&P 500 and buoys the declining exposure of healthcare stocks.

Despite facing significant headwinds with regulatory scrutiny, investment data display a gradual yet definite transition towards healthcare stocks. This shift in sentiment is backed by a model that accurately recounts the investor trend.

Is it too late to buy healthcare stocks? Given the track record of the authors, they strongly recommend considering the current performance of healthcare, Wall Street’s GDP growth expectations before making a decision.

The authors of this article, Todd Campbell and Daniel Kline, leverage their vast experience and unique perspectives to shed light on this interesting trend for the upcoming year.